Pump thrombosis: Difference between revisions
From Food & Medicine Encyclopedia
No edit summary |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Pump thrombosis | |||
| synonyms = | |||
| field = [[Cardiology]] | |||
| symptoms = [[Heart failure]], [[shortness of breath]], [[fatigue]], [[chest pain]] | |||
| complications = [[Stroke]], [[heart attack]], [[device malfunction]] | |||
| onset = | |||
| duration = | |||
| types = | |||
| causes = [[Blood clot]] formation in [[ventricular assist device]] | |||
| risks = [[Mechanical heart valve]], [[coagulation disorders]], inadequate [[anticoagulation]] | |||
| diagnosis = [[Echocardiography]], [[blood tests]], [[device interrogation]] | |||
| differential = | |||
| prevention = Adequate [[anticoagulation therapy]], regular [[device monitoring]] | |||
| treatment = [[Anticoagulation]], [[thrombolysis]], [[device replacement]] | |||
| prognosis = Variable, depending on severity and treatment | |||
| frequency = | |||
| deaths = | |||
}} | |||
'''Pump thrombosis''' is a serious complication associated with the use of [[ventricular assist devices]] (VADs), which are mechanical pumps used to support heart function and blood flow in individuals with weakened hearts. This condition involves the formation of a [[blood clot]] within the pump, which can lead to [[device malfunction]] and serious clinical consequences. | '''Pump thrombosis''' is a serious complication associated with the use of [[ventricular assist devices]] (VADs), which are mechanical pumps used to support heart function and blood flow in individuals with weakened hearts. This condition involves the formation of a [[blood clot]] within the pump, which can lead to [[device malfunction]] and serious clinical consequences. | ||
==Pathophysiology== | ==Pathophysiology== | ||
Pump thrombosis occurs when a [[thrombus]] forms within the [[ventricular assist device]]. This can obstruct blood flow, leading to increased [[pump power consumption]] and potential [[device failure]]. The formation of a thrombus is influenced by several factors, including blood flow dynamics, [[shear stress]], and the [[coagulation cascade]]. | Pump thrombosis occurs when a [[thrombus]] forms within the [[ventricular assist device]]. This can obstruct blood flow, leading to increased [[pump power consumption]] and potential [[device failure]]. The formation of a thrombus is influenced by several factors, including blood flow dynamics, [[shear stress]], and the [[coagulation cascade]]. | ||
==Risk Factors== | ==Risk Factors== | ||
Several risk factors contribute to the development of pump thrombosis: | Several risk factors contribute to the development of pump thrombosis: | ||
| Line 10: | Line 28: | ||
* '''Suboptimal anticoagulation''': Inadequate [[anticoagulation therapy]] can lead to thrombus formation. | * '''Suboptimal anticoagulation''': Inadequate [[anticoagulation therapy]] can lead to thrombus formation. | ||
* '''Patient-related factors''': Individual patient characteristics, such as [[genetic predisposition]] and [[comorbidities]], can affect thrombosis risk. | * '''Patient-related factors''': Individual patient characteristics, such as [[genetic predisposition]] and [[comorbidities]], can affect thrombosis risk. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
Patients with pump thrombosis may present with: | Patients with pump thrombosis may present with: | ||
| Line 18: | Line 35: | ||
* [[Hemolysis]], indicated by elevated [[lactate dehydrogenase]] (LDH) levels | * [[Hemolysis]], indicated by elevated [[lactate dehydrogenase]] (LDH) levels | ||
* [[Device alarms]] indicating increased power consumption | * [[Device alarms]] indicating increased power consumption | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of pump thrombosis involves a combination of clinical assessment and diagnostic tests: | The diagnosis of pump thrombosis involves a combination of clinical assessment and diagnostic tests: | ||
| Line 24: | Line 40: | ||
* '''Blood tests''': Elevated LDH and [[plasma-free hemoglobin]] levels can indicate hemolysis due to pump thrombosis. | * '''Blood tests''': Elevated LDH and [[plasma-free hemoglobin]] levels can indicate hemolysis due to pump thrombosis. | ||
* '''Device interrogation''': Analyzing device parameters such as power consumption and flow rates can help identify thrombosis. | * '''Device interrogation''': Analyzing device parameters such as power consumption and flow rates can help identify thrombosis. | ||
==Management== | ==Management== | ||
Management of pump thrombosis includes: | Management of pump thrombosis includes: | ||
| Line 30: | Line 45: | ||
* '''[[Thrombolysis]]''': Use of thrombolytic agents to dissolve the thrombus. | * '''[[Thrombolysis]]''': Use of thrombolytic agents to dissolve the thrombus. | ||
* '''Device replacement''': In severe cases, surgical replacement of the VAD may be necessary. | * '''Device replacement''': In severe cases, surgical replacement of the VAD may be necessary. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis of pump thrombosis depends on the timeliness and effectiveness of treatment. Prompt intervention can prevent serious complications such as [[stroke]] and [[heart failure]]. | The prognosis of pump thrombosis depends on the timeliness and effectiveness of treatment. Prompt intervention can prevent serious complications such as [[stroke]] and [[heart failure]]. | ||
==Prevention== | ==Prevention== | ||
Preventive strategies include: | Preventive strategies include: | ||
| Line 39: | Line 52: | ||
* Regular monitoring of device function and patient status. | * Regular monitoring of device function and patient status. | ||
* Use of devices with lower thrombosis risk profiles. | * Use of devices with lower thrombosis risk profiles. | ||
==See Also== | ==See Also== | ||
* [[Ventricular assist device]] | * [[Ventricular assist device]] | ||
Latest revision as of 00:06, 4 April 2025
| Pump thrombosis | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Heart failure, shortness of breath, fatigue, chest pain |
| Complications | Stroke, heart attack, device malfunction |
| Onset | |
| Duration | |
| Types | |
| Causes | Blood clot formation in ventricular assist device |
| Risks | Mechanical heart valve, coagulation disorders, inadequate anticoagulation |
| Diagnosis | Echocardiography, blood tests, device interrogation |
| Differential diagnosis | |
| Prevention | Adequate anticoagulation therapy, regular device monitoring |
| Treatment | Anticoagulation, thrombolysis, device replacement |
| Medication | N/A |
| Prognosis | Variable, depending on severity and treatment |
| Frequency | |
| Deaths | |
Pump thrombosis is a serious complication associated with the use of ventricular assist devices (VADs), which are mechanical pumps used to support heart function and blood flow in individuals with weakened hearts. This condition involves the formation of a blood clot within the pump, which can lead to device malfunction and serious clinical consequences.
Pathophysiology[edit]
Pump thrombosis occurs when a thrombus forms within the ventricular assist device. This can obstruct blood flow, leading to increased pump power consumption and potential device failure. The formation of a thrombus is influenced by several factors, including blood flow dynamics, shear stress, and the coagulation cascade.
Risk Factors[edit]
Several risk factors contribute to the development of pump thrombosis:
- Hypercoagulability: Conditions that increase the tendency of blood to clot can predispose patients to pump thrombosis.
- Device-related factors: The design and material of the VAD can influence thrombosis risk. Some devices have higher thrombosis rates due to their design.
- Suboptimal anticoagulation: Inadequate anticoagulation therapy can lead to thrombus formation.
- Patient-related factors: Individual patient characteristics, such as genetic predisposition and comorbidities, can affect thrombosis risk.
Clinical Presentation[edit]
Patients with pump thrombosis may present with:
- Dyspnea
- Fatigue
- Signs of heart failure
- Hemolysis, indicated by elevated lactate dehydrogenase (LDH) levels
- Device alarms indicating increased power consumption
Diagnosis[edit]
The diagnosis of pump thrombosis involves a combination of clinical assessment and diagnostic tests:
- Echocardiography: Used to assess heart function and detect thrombus formation.
- Blood tests: Elevated LDH and plasma-free hemoglobin levels can indicate hemolysis due to pump thrombosis.
- Device interrogation: Analyzing device parameters such as power consumption and flow rates can help identify thrombosis.
Management[edit]
Management of pump thrombosis includes:
- Anticoagulation therapy: Intensifying anticoagulation to prevent further thrombus formation.
- Thrombolysis: Use of thrombolytic agents to dissolve the thrombus.
- Device replacement: In severe cases, surgical replacement of the VAD may be necessary.
Prognosis[edit]
The prognosis of pump thrombosis depends on the timeliness and effectiveness of treatment. Prompt intervention can prevent serious complications such as stroke and heart failure.
Prevention[edit]
Preventive strategies include:
- Optimizing anticoagulation therapy to maintain therapeutic levels.
- Regular monitoring of device function and patient status.
- Use of devices with lower thrombosis risk profiles.
See Also[edit]
Cardiovascular disease A-Z
Most common cardiac diseases
- Cardiac arrhythmia
- Cardiogenetic disorders
- Cardiomegaly
- Cardiomyopathy
- Cardiopulmonary resuscitation
- Chronic rheumatic heart diseases
- Congenital heart defects
- Heart neoplasia
- Ischemic heart diseases
- Pericardial disorders
- Syndromes affecting the heart
- Valvular heart disease
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A[edit]
- Accelerated idioventricular rhythm
- Acute decompensated heart failure
- Arteriosclerotic heart disease
- Athletic heart syndrome
- Atrial flutter
- Atrioventricular fistula
- Cardiovascular disease in Australia
- Autoimmune heart disease
B[edit]
C[edit]
- Ebb Cade
- Cardiac allograft vasculopathy
- Cardiac amyloidosis
- Cardiac asthma
- Cardiac tamponade
- Cardiogenic shock
- Cardiogeriatrics
- Cardiorenal syndrome
- Cardiotoxicity
- Carditis
- Coronary artery aneurysm
- Coronary artery anomaly
- Coronary artery disease
- Spontaneous coronary artery dissection
- Coronary artery ectasia
- Coronary occlusion
- Coronary steal
- Coronary thrombosis
- Coronary vasospasm
- Cœur en sabot
- Coxsackievirus-induced cardiomyopathy
D[edit]
E[edit]
H[edit]
- Heart attack
- Heart failure
- Heart failure with preserved ejection fraction
- Heart to Heart (1949 film)
- High-output heart failure
- Hyperdynamic precordium
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
I[edit]
- Idiopathic giant-cell myocarditis
- Interventricular dyssynchrony
- Intraventricular dyssynchrony
- Isolated atrial amyloidosis
K[edit]
L[edit]
M[edit]
- Mydicar
- Myocardial bridge
- Myocardial disarray
- Myocardial rupture
- Myocardial scarring
- Myocardial stunning
- Myocarditis
N[edit]
O[edit]
P[edit]
- Papillary fibroelastoma
- Pathophysiology of heart failure
- Postpericardiotomy syndrome
- Pulmonary vein stenosis
R[edit]
S[edit]
- Saturated fat and cardiovascular disease
- SCAR-Fc
- Shone's syndrome
- Strain pattern
- Subacute bacterial endocarditis
- Sudden cardiac death of athletes
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
T[edit]
V[edit]
W[edit]
